In patients with renal impairment, rocuronium and sugammadex are the primary choice for reversing neuromuscular blockade, ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Today, hospitalists are so deeply integrated into many organizations that it might be hard to remember this role has only ...

Steroid shots have limited efficacy in reducing pain and disability associated with chronic back pain, an updated data ...

Insecure attachment and anxiety fuel emotional dependence, with new research offering key insights for targeted interventions.

A tool that screens for molecules that may have therapeutic value against drug-resistant bacteria has been released for free ...

Funding freezes, legal fights, chaos — no one in medical research knows what will come, except that as of January 22, 2025, ...

Fourth-year medical students discuss skills learned beyond formal instruction; the things med school doesn’t teach.

Cannabis use disorder requiring hospital-based care is linked to an increased risk for premature death in a new cohort study.

The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...